GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior.

Authors:
Samms RJ; Cosgrove R; Snider BM; Furber EC; Droz BA and 11 more

Journal:
Diabetes

Publication Year: 2022

DOI:
10.2337/db21-0848

PMCID:
PMC9233244

PMID:
35499381

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. R.J.S., R.C., B.M.S., E.C.F., B.A.D., D.A.B., J.D., M.D., J.A.-F., T.C., K.W.S., P.J.E., and M.A. are current or past employees of Eli Lilly and Company. B.C.D.J. and M.R.H. receive research funding for an investigator-initiated proposal from Eli Lilly and Company. No other potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Duality of Interest. R.J.S., R.C., B.M.S., E.C.F., B.A.D., D.A.B., J.D., M.D., J.A.-F., T.C., K.W.S., P.J.E., and M.A. are current or past employees of Eli Lilly and Company. B.C.D.J. and M.R.H. receive research funding for an investigator-initiated proposal from Eli Lilly and Company. No other potential conflicts of interest relevant to this article were reported."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025